Report Detail
Global Blood Plasma Derivatives Market Insights, Forecast to 2025
- RnM2362212 |
- 19 June, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Other
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
The global Blood Plasma Derivatives market is valued at 24800 million US$ in 2018 and will reach 52000 million US$ by the end of 2025, growing at a CAGR of 9.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Blood Plasma Derivatives market based on company, product type, end user and key regions.
This report studies the global market size of Blood Plasma Derivatives in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Plasma Derivatives in these regions.
This research report categorizes the global Blood Plasma Derivatives market by top players/brands, region, type and end user. This report also studies the global Blood Plasma Derivatives market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Grifols
SK Plasma
Fusion Health Care
Biotest AG
Green Cross Corporation
Baxter International
LFB
Octapharma AG
CSL Limited
Shire Plc.
China Biologic Products
Kedrion Biopharma
BDI Pharma
Bayer AG
Hualan Biological Engineering
Market size by Product
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Market size by End User
Hospitals
Clinics
Other End Users
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Blood Plasma Derivatives market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Blood Plasma Derivatives market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Plasma Derivatives companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Plasma Derivatives submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Blood Plasma Derivatives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Plasma Derivatives market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Blood Plasma Derivatives Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Blood Plasma Derivatives Market Size Growth Rate by Product
- 1.4.2 Albumin
- 1.4.3 Factor VIII
- 1.4.4 Factor IX
- 1.4.5 Immunoglobulin
- 1.4.6 Hyperimmune Globulin
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Blood Plasma Derivatives Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Other End Users
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Blood Plasma Derivatives Market Size
- 2.1.1 Global Blood Plasma Derivatives Revenue 2014-2025
- 2.1.2 Global Blood Plasma Derivatives Sales 2014-2025
- 2.2 Blood Plasma Derivatives Growth Rate by Regions
- 2.2.1 Global Blood Plasma Derivatives Sales by Regions
- 2.2.2 Global Blood Plasma Derivatives Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Blood Plasma Derivatives Sales by Manufacturers
- 3.1.1 Blood Plasma Derivatives Sales by Manufacturers
- 3.1.2 Blood Plasma Derivatives Sales Market Share by Manufacturers
- 3.1.3 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
- 3.2 Blood Plasma Derivatives Revenue by Manufacturers
- 3.2.1 Blood Plasma Derivatives Revenue by Manufacturers (2014-2019)
- 3.2.2 Blood Plasma Derivatives Revenue Share by Manufacturers (2014-2019)
- 3.3 Blood Plasma Derivatives Price by Manufacturers
- 3.4 Blood Plasma Derivatives Manufacturing Base Distribution, Product Types
- 3.4.1 Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Blood Plasma Derivatives Product Type
- 3.4.3 Date of International Manufacturers Enter into Blood Plasma Derivatives Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Blood Plasma Derivatives Sales by Product
- 4.2 Global Blood Plasma Derivatives Revenue by Product
- 4.3 Blood Plasma Derivatives Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Blood Plasma Derivatives Breakdown Data by End User
6 North America
- 6.1 North America Blood Plasma Derivatives by Countries
- 6.1.1 North America Blood Plasma Derivatives Sales by Countries
- 6.1.2 North America Blood Plasma Derivatives Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Blood Plasma Derivatives by Product
- 6.3 North America Blood Plasma Derivatives by End User
7 Europe
- 7.1 Europe Blood Plasma Derivatives by Countries
- 7.1.1 Europe Blood Plasma Derivatives Sales by Countries
- 7.1.2 Europe Blood Plasma Derivatives Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Blood Plasma Derivatives by Product
- 7.3 Europe Blood Plasma Derivatives by End User
8 Asia Pacific
- 8.1 Asia Pacific Blood Plasma Derivatives by Countries
- 8.1.1 Asia Pacific Blood Plasma Derivatives Sales by Countries
- 8.1.2 Asia Pacific Blood Plasma Derivatives Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Blood Plasma Derivatives by Product
- 8.3 Asia Pacific Blood Plasma Derivatives by End User
9 Central & South America
- 9.1 Central & South America Blood Plasma Derivatives by Countries
- 9.1.1 Central & South America Blood Plasma Derivatives Sales by Countries
- 9.1.2 Central & South America Blood Plasma Derivatives Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Blood Plasma Derivatives by Product
- 9.3 Central & South America Blood Plasma Derivatives by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Blood Plasma Derivatives by Countries
- 10.1.1 Middle East and Africa Blood Plasma Derivatives Sales by Countries
- 10.1.2 Middle East and Africa Blood Plasma Derivatives Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Blood Plasma Derivatives by Product
- 10.3 Middle East and Africa Blood Plasma Derivatives by End User
11 Company Profiles
- 11.1 Grifols
- 11.1.1 Grifols Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Grifols Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Grifols Blood Plasma Derivatives Products Offered
- 11.1.5 Grifols Recent Development
- 11.2 SK Plasma
- 11.2.1 SK Plasma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 SK Plasma Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 SK Plasma Blood Plasma Derivatives Products Offered
- 11.2.5 SK Plasma Recent Development
- 11.3 Fusion Health Care
- 11.3.1 Fusion Health Care Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Fusion Health Care Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Fusion Health Care Blood Plasma Derivatives Products Offered
- 11.3.5 Fusion Health Care Recent Development
- 11.4 Biotest AG
- 11.4.1 Biotest AG Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Biotest AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Biotest AG Blood Plasma Derivatives Products Offered
- 11.4.5 Biotest AG Recent Development
- 11.5 Green Cross Corporation
- 11.5.1 Green Cross Corporation Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Green Cross Corporation Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Green Cross Corporation Blood Plasma Derivatives Products Offered
- 11.5.5 Green Cross Corporation Recent Development
- 11.6 Baxter International
- 11.6.1 Baxter International Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Baxter International Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Baxter International Blood Plasma Derivatives Products Offered
- 11.6.5 Baxter International Recent Development
- 11.7 LFB
- 11.7.1 LFB Company Details
- 11.7.2 Company Business Overview
- 11.7.3 LFB Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 LFB Blood Plasma Derivatives Products Offered
- 11.7.5 LFB Recent Development
- 11.8 Octapharma AG
- 11.8.1 Octapharma AG Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Octapharma AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Octapharma AG Blood Plasma Derivatives Products Offered
- 11.8.5 Octapharma AG Recent Development
- 11.9 CSL Limited
- 11.9.1 CSL Limited Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CSL Limited Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CSL Limited Blood Plasma Derivatives Products Offered
- 11.9.5 CSL Limited Recent Development
- 11.10 Shire Plc.
- 11.10.1 Shire Plc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Shire Plc. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Shire Plc. Blood Plasma Derivatives Products Offered
- 11.10.5 Shire Plc. Recent Development
- 11.11 China Biologic Products
- 11.12 Kedrion Biopharma
- 11.13 BDI Pharma
- 11.14 Bayer AG
- 11.15 Hualan Biological Engineering
12 Future Forecast
- 12.1 Blood Plasma Derivatives Market Forecast by Regions
- 12.1.1 Global Blood Plasma Derivatives Sales Forecast by Regions 2019-2025
- 12.1.2 Global Blood Plasma Derivatives Revenue Forecast by Regions 2019-2025
- 12.2 Blood Plasma Derivatives Market Forecast by Product
- 12.2.1 Global Blood Plasma Derivatives Sales Forecast by Product 2019-2025
- 12.2.2 Global Blood Plasma Derivatives Revenue Forecast by Product 2019-2025
- 12.3 Blood Plasma Derivatives Market Forecast by End User
- 12.4 North America Blood Plasma Derivatives Forecast
- 12.5 Europe Blood Plasma Derivatives Forecast
- 12.6 Asia Pacific Blood Plasma Derivatives Forecast
- 12.7 Central & South America Blood Plasma Derivatives Forecast
- 12.8 Middle East and Africa Blood Plasma Derivatives Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Blood Plasma Derivatives Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Blood Plasma Derivatives . Industry analysis & Market Report on Blood Plasma Derivatives is a syndicated market report, published as Global Blood Plasma Derivatives Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Blood Plasma Derivatives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
